source
- Merck and Kelun-Biotech's ADC sac-TMT secures first global Phase 3 win ahead of scheduleMerck and China-based Kelun-Biotech reported that their experimental antibody-drug conjugate sac-TMT achieved a positive outcome in a global Phase 3 study, marking the first such success for the ca…
- Maryland board caps Ozempic price at $274 per month, aiming to save $5.8 million annuallyMaryland's Prescription Drug Affordability Board announced a price ceiling for Ozempic, a type 2 diabetes medication. The cap limits the cost of a 30‑day supply to $274, a figure based on Medicare…